CADE DAVID NORMAN enters TELIX PHARMACEUTICALS LTD with 373.13K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/1/2026ACC: 0001628280-26-022572
Officer· Group Chief Medical Officer
Since Mar 2026
373.13K
Baseline shares
100% direct
373.13K
Direct ownership
1 position
175.05K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned373.13K
Total
373.13K direct373.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 373.13K | Direct |
| Total | 373.13K | 373.13K direct |
Derivative Holdings4
Performance Share Appreciation Rights (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
78.19K
Shares owned
N/A
Exercise price
4.95
Expiration
—
Exercise window
—
Share Rights
DirectUnderlying security
Ordinary Shares
Underlying shares
11.49K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Share Rights
DirectUnderlying security
Ordinary Shares
Underlying shares
1.08K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Performance Share Appreciation Rights (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
84.29K
Shares owned
N/A
Exercise price
6.90
Expiration
—
Exercise window
—
Total
Underlying
175.05K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 4.95 | — | — | 78.19K | N/A |
| Share Rights Direct | Ordinary Shares | 0 | — | — | 11.49K | N/A |
| Share Rights Direct | Ordinary Shares | 0 | — | — | 1.08K | N/A |
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 6.90 | — | — | 84.29K | N/A |
| Total | 175.05K | 0.00 | ||||